1. Aoki J, Nakazawa G, Tanabe K, et al. Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. 2007. 69:380–386.
2. Lee MS, Jurewitz D, Aragon J, Forrester J, Makkar RR, Kar S. Stent fracture associated with drug-eluting stents: clinical characteristics and implications. Catheter Cardiovasc Interv. 2007. 69:387–394.
3. Doi H, Maehara A, Mintz GS, et al. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol. 2009. 103:818–823.
4. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006. 113:414–419.
5. Aoki J, Kirtane A, Leon MB, Dangas G. Coranary artery aneurysm after drug-eluting stent implantation. JACC Cardiovasc Interv. 2008. 1:14–21.
6. Lee SY, Im E, Yang WI, Kim JS, Cho YH, Shim WH. A sirolimus: eluting stent fracture combined with a coronary artery aneurysm. Korean Circ J. 2008. 38:69–71.
7. Tizón-Marcos H, De Larochellière R, Larose E. Breakpoint: left main stent fracture: review of the literature. J Interv Cardiol. 2009. 22:362–367.
8. Adlakha S, Sheikh M, Bruhl S, et al. Coronary stent fracture: a cause of cardiac chest pain? Int J Cardiol. 2010. 141:e23–e25.
9. Bergelson BA, Tommaso CL. Left main coronary artery disease: assessment, diagnosis, and therapy. Am Heart J. 1995. 129:350–359.
10. Kim EJ, Rha SW, Wani SP, et al. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management? Int J Cardiol. 2007. 120:417–419.
11. Liao R, Green NE, Chen SY, et al. Three-dimensional analysis of in vivo coronary stent: coronary artery interactions. Int J Cardiovasc Imaging. 2004. 20:305–313.